MENTAL RETARDATION, AUTOSOMAL DOMINANT 34
0.600
GeneticVariation
disease
UNIPROT
Large-scale discovery of novel genetic causes of developmental disorders.
25533962
2015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 34
0.600
GeneticVariation
disease
UNIPROT
De novo mutations in moderate or severe intellectual disability.
25356899
2014
MENTAL RETARDATION, AUTOSOMAL DOMINANT 34
0.600
CausalMutation
disease
CLINVAR
MENTAL RETARDATION, AUTOSOMAL DOMINANT 34
0.600
Biomarker
disease
CTD_human
Intellectual Disability
0.400
Biomarker
group
GENOMICS_ENGLAND
Large-scale discovery of novel genetic causes of developmental disorders.
25533962
2015
Intellectual Disability
0.400
Biomarker
group
HPO
Epilepsy
0.300
Biomarker
disease
CTD_human
De novo variants in neurodevelopmental disorders with epilepsy.
29942082
2018
Epilepsy, Cryptogenic
0.300
Biomarker
disease
CTD_human
De novo variants in neurodevelopmental disorders with epilepsy.
29942082
2018
×
CUI:
C0236018
Disease:
Aura
Aura
0.300
Biomarker
phenotype
CTD_human
De novo variants in neurodevelopmental disorders with epilepsy.
29942082
2018
Awakening Epilepsy
0.300
Biomarker
disease
CTD_human
De novo variants in neurodevelopmental disorders with epilepsy.
29942082
2018
Neurodevelopmental Disorders
0.300
Biomarker
group
CTD_human
De novo variants in neurodevelopmental disorders with epilepsy.
29942082
2018
Neurodevelopmental Disorders
0.300
Biomarker
group
CTD_human
Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases.
28191889
2017
Non-Small Cell Lung Carcinoma
0.300
Biomarker
disease
CTD_human
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839).
15496427
2004
Malignant Neoplasms
0.130
Biomarker
group
BEFREE
Dysregulation of the ceramide transport protein CERT is associated to diseases such as cancer .
31757669
2020
Malignant Neoplasms
0.130
Biomarker
group
BEFREE
Here we demonstrate that cancer EMT phenotypes secrete GPBP (mesenchymal GPBP ) which displays a predominant multimeric oligomerization and directs the formation of previously unrecognized mesh collagen IV networks (mesenchymal collagen IV).
29541394
2018
Malignant Neoplasms
0.130
GeneticVariation
group
GWASCAT
Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases.
27790247
2016
Malignant Neoplasms
0.130
Biomarker
group
BEFREE
CERT depletion predicts chemotherapy benefit and mediates cytotoxic and polyploid-specific cancer cell death through autophagy induction.
21953249
2012
Alcohol consumption
0.100
GeneticVariation
phenotype
GWASCAT
Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions.
30698716
2019
Cardiovascular Diseases
0.100
GeneticVariation
group
GWASCAT
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
30595370
2019
Low density lipoprotein cholesterol measurement
0.100
GeneticVariation
phenotype
GWASCAT
Multi-ancestry genome-wide gene-smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids.
30926973
2019
Low density lipoprotein cholesterol measurement
0.100
GeneticVariation
phenotype
GWASCAT
Multi-ancestry study of blood lipid levels identifies four loci interacting with physical activity.
30670697
2019
Low density lipoprotein cholesterol measurement
0.100
GeneticVariation
phenotype
GWASCAT
Genetic analyses of diverse populations improves discovery for complex traits.
31217584
2019
Low density lipoprotein cholesterol measurement
0.100
GeneticVariation
phenotype
GWASCAT
Multiancestry Genome-Wide Association Study of Lipid Levels Incorporating Gene-Alcohol Interactions.
30698716
2019
Serum total cholesterol measurement
0.100
GeneticVariation
phenotype
GWASCAT
Genetic analyses of diverse populations improves discovery for complex traits.
31217584
2019
Low density lipoprotein cholesterol measurement
0.100
GeneticVariation
phenotype
GWASCAT
A large electronic-health-record-based genome-wide study of serum lipids.
29507422
2018